Literature DB >> 12435392

Cell membrane translocation of the N-terminal (1-28) part of the prion protein.

P Lundberg1, M Magzoub, M Lindberg, M Hällbrink, J Jarvet, L E G Eriksson, U Langel, A Gräslund.   

Abstract

The N-terminal (1-28) part of the mouse prion protein (PrP) is a cell penetrating peptide, capable of transporting large hydrophilic cargoes through a cell membrane. Confocal fluorescence microscopy shows that it transports the protein avidin (67kDa) into several cell lines. The (1-28) peptide has a strong tendency for aggregation and beta-structure formation, particularly in interaction with negatively charged phospholipid membranes. The findings have implications for how prion proteins with uncleaved signal peptides in the N-termini may enter into cells, which is important for infection. The secondary structure conversion into beta-structure may be relevant as a seed for the conversion into the scrapie (PrP(Sc)) form of the protein and its amyloidic transformation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435392     DOI: 10.1016/s0006-291x(02)02595-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Development of viral nanoparticles for efficient intracellular delivery.

Authors:  Zhuojun Wu; Kevin Chen; Ibrahim Yildiz; Anouk Dirksen; Rainer Fischer; Philip E Dawson; Nicole F Steinmetz
Journal:  Nanoscale       Date:  2012-04-16       Impact factor: 7.790

2.  Gene Silencing Mediated by siRNA-binding Fusion Proteins Is Attenuated by Double-stranded RNA-binding Domain Structure.

Authors:  James C Geoghegan; Brian L Gilmore; Beverly L Davidson
Journal:  Mol Ther Nucleic Acids       Date:  2012-11-13       Impact factor: 10.183

3.  Functional cell permeable motifs within medically relevant proteins.

Authors:  Walter Low; Alison Mortlock; Liljana Petrovska; Tania Dottorini; Gordon Dougan; Andrea Crisanti
Journal:  J Biotechnol       Date:  2007-02-01       Impact factor: 3.307

Review 4.  Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.

Authors:  Roger Gilabert-Oriol; Alexander Weng; Benedicta von Mallinckrodt; Matthias F Melzig; Hendrik Fuchs; Mayank Thakur
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

5.  Mutational analysis of PRNP in Alzheimer's disease and frontotemporal dementia in China.

Authors:  Weiwei Zhang; Bin Jiao; Tingting Xiao; Chuzheng Pan; Xixi Liu; Lin Zhou; Beisha Tang; Lu Shen
Journal:  Sci Rep       Date:  2016-12-02       Impact factor: 4.379

6.  Alterations in the brain interactome of the intrinsically disordered N-terminal domain of the cellular prion protein (PrPC) in Alzheimer's disease.

Authors:  Sarah Ulbrich; Petra Janning; Ralf Seidel; Jakob Matschke; Anika Gonsberg; Sebastian Jung; Markus Glatzel; Martin Engelhard; Konstanze F Winklhofer; Jörg Tatzelt
Journal:  PLoS One       Date:  2018-05-23       Impact factor: 3.240

7.  Recent developments in peptide-based nucleic acid delivery.

Authors:  Sandra Veldhoen; Sandra D Laufer; Tobias Restle
Journal:  Int J Mol Sci       Date:  2008-07-16       Impact factor: 6.208

Review 8.  Building Cell Selectivity into CPP-Mediated Strategies.

Authors:  Irene Martín; Meritxell Teixidó; Ernest Giralt
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-14

9.  Serum stability and physicochemical characterization of a novel amphipathic peptide C6M1 for siRNA delivery.

Authors:  Mousa Jafari; Wen Xu; Ran Pan; Chad M Sweeting; Desiree Nedra Karunaratne; Pu Chen
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

Review 10.  Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases.

Authors:  Eva Bagyinszky; Vo Van Giau; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-14       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.